Cyclin-dependent kinase inhibitor p27 as a prognostic biomarker and potential cancer therapeutic target

By Hershko Dan D  

Future Oncology, Vol. 6, Iss. 12, 2010-12 ,pp. : 1837-1847

Future Medicine

Access to resources Recommend Favorite

SAR103168: a tyrosine kinase inhibitor with therapeutic potential in myeloid leukemias

By Bourrié Bernard  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1488-1499

Informa Healthcare

Access to resources Recommend Favorite

Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target

By                

International Journal of Oncology, Vol. 42, Iss. 1, 2013-01 ,pp. : 44-54

Spandidos Publications

Access to resources Recommend Favorite

P21-Activated Kinase 1 (PAK1) as a Therapeutic Target in BRAF Wild-Type Melanoma

By Ong Christy C.   Jubb Adrian M.   Jakubiak Diana   Zhou Wei   Rudolph Joachim   Haverty Peter M.   Kowanetz Marcin   Yan Yibing   Tremayne Jarrod   Lisle Richard   Harris Adrian L.   Friedman Lori S.   Belvin Marcia   Middleton Mark R.   Blackwood Elizabeth M.   Koeppen Hartmut   Hoeflich Klaus P.  

Journal of the National Cancer Institute, Vol. 105, Iss. 9, 2013-05 ,pp. : 606-607

Oxford University Press

Access to resources Recommend Favorite

Melanin as a potential target for radionuclide therapy of metastatic melanoma

By Dadachova Ekaterina   Casadevall Arturo  

Future Oncology, Vol. 1, Iss. 4, 2005-08 ,pp. : 541-549

Future Medicine

Access to resources Recommend Favorite